Posted inNews and Updates
FDA Clears Clinical Trial for Mabwell’s 6MW5311 Therapy
The FDA has approved the clinical trial application for Mabwell’s 6MW5311 injection. Learn more about this new development in targeted biologic therapy.
Posted inNews and Updates
Algenomics Shares Promising RZ-001 Results for Glioblastoma
Algenomics reports promising interim data for RZ-001 in treating recurrent glioblastoma. Discover the latest clinical updates from the ASNO conference.
Posted inNews and Updates
Laxative Drug Shows Potential to Ease Depression Brain Fog
New research suggests a common laxative may help treat cognitive "brain fog" in depressed patients by targeting the gut-brain axis. Read the latest findings.
Posted inNews and Updates
Qurucell Reports Positive Phase 2 Data for Limcato CAR-T
New Phase 2 results reveal high efficacy for Qurucell’s Limcato CAR-T therapy, showing promising remission rates for patients with refractory blood cancer.
Posted inNews and Updates
Anna Friel Leads New Medical Drama The F Ward: What to Know
Discover the new medical drama 'The F Ward' starring Anna Friel. Get the latest on the series launch, plot, and its portrayal of real-world hospital life.
Posted inNews and Updates
Rocket Pharma Gains $180M Selling Rare Pediatric Voucher
Rocket Pharmaceuticals sells its FDA Priority Review Voucher for $180M. Learn how this strategic divestiture boosts gene therapy R&D and market liquidity.
Posted inNews and Updates
United Laboratories TUL321 Clinical Trial: What to Know
United Laboratories has gained approval for its new TUL321 clinical trial. Discover how this development impacts the company's valuation and R&D outlook.
Posted inNews and Updates
Investment Scams: How Fake Stock Apps Target Retirees
An Ahmedabad retiree lost ₹1.21 crore to a sophisticated stock market scam. Learn how to spot fake trading apps and protect your investments from fraud.
Posted inNews and Updates
DR Congo Ebola Outbreak Nears 600 Cases: Urgent Alert
The DRC reports nearly 600 Ebola cases, prompting global health alerts regarding regional transmission risks and the urgent need for enhanced containment efforts.
Posted inNews and Updates
New Study Links GLP-1 Use to Reduced Breast Cancer Risk
Emerging research indicates a 30% reduction in breast cancer incidence among GLP-1 users. We analyze the clinical implications for metabolic and oncology care.